{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:15:37Z","timestamp":1792516537721,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-15-IDEX-02"],"award-info":[{"award-number":["ANR-15-IDEX-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019979","name":"Fondation Universit\u00e9 Grenoble Alpes","doi-asserted-by":"publisher","award":["ANR-19-P3IA-0003"],"award-info":[{"award-number":["ANR-19-P3IA-0003"]}],"id":[{"id":"10.13039\/100019979","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.sleep.2025.02.003","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T12:13:31Z","timestamp":1738757611000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Efficacy and safety of pitolisant in residual excessive daytime sleepiness for patients with obstructive sleep apnea adhering to continuous positive airway pressure therapy in the HAROSA studies: An individual patient meta-analytical approach"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7303-9799","authenticated-orcid":false,"given":"Dries","family":"Testelmans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lehert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerryll","family":"Asin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Imschoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Causs\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"P\u00e9pin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2025.02.003_bib1","doi-asserted-by":"crossref","first-page":"15015","DOI":"10.1038\/nrdp.2015.15","article-title":"Obstructive sleep apnoea syndrome","volume":"1","author":"Levy","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"10.1016\/j.sleep.2025.02.003_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","article-title":"Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis","volume":"7","author":"Benjafield","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.sleep.2025.02.003_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157318","article-title":"Obstructive sleep apnea: a Cluster analysis at time of diagnosis","volume":"11","author":"Bailly","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.sleep.2025.02.003_bib4","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S2213-2600(15)00090-9","article-title":"Sleep apnoea and the brain: a complex relationship","volume":"3","author":"Rosenzweig","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.sleep.2025.02.003_bib5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/00325481.2021.1948305","article-title":"Residual excessive daytime sleepiness in patients treated for obstructive sleep apnea: guidance for assessment, diagnosis, and management","volume":"133","author":"Rosenberg","year":"2021","journal-title":"Postgrad Med J"},{"issue":"5","key":"10.1016\/j.sleep.2025.02.003_bib6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1513\/AnnalsATS.202006-696FR","article-title":"Excessive daytime sleepiness in obstructive sleep apnea. Mechanisms and clinical management","volume":"18","author":"Lal","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.sleep.2025.02.003_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/sleep\/34.1.111","article-title":"The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA","volume":"34","author":"Antic","year":"2011","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.sleep.2025.02.003_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00348-2017","article-title":"Predictors of sleepiness in obstructive sleep apnoea at baseline and after 6 months of continuous positive airway pressure therapy","volume":"50","author":"Budhiraja","year":"2017","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.sleep.2025.02.003_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5664\/jcsm.27497","article-title":"Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults","volume":"5","author":"Epstein","year":"2009","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"10.1016\/j.sleep.2025.02.003_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11325-019-01830-6","article-title":"Residual excessive daytime sleepiness in patients with obstructive sleep apnea treated with positive airway pressure therapy","volume":"24","author":"Foster","year":"2020","journal-title":"Sleep Breath"},{"issue":"4","key":"10.1016\/j.sleep.2025.02.003_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jsr.12039","article-title":"Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure","volume":"22","author":"Gasa","year":"2013","journal-title":"J Sleep Res"},{"issue":"2","key":"10.1016\/j.sleep.2025.02.003_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5664\/jcsm.7640","article-title":"Treatment of adult obstructive sleep apnea with positive airway pressure: an American academy of sleep medicine clinical practice guideline","volume":"15","author":"Patil","year":"2019","journal-title":"J Clin Sleep Med"},{"issue":"5","key":"10.1016\/j.sleep.2025.02.003_bib13","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1183\/09031936.00016808","article-title":"Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study","volume":"33","author":"Pepin","year":"2009","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.sleep.2025.02.003_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/sleep\/30.6.711","article-title":"Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning","volume":"30","author":"Weaver","year":"2007","journal-title":"Sleep"},{"issue":"164","key":"10.1016\/j.sleep.2025.02.003_bib15","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0230-2021","article-title":"Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view","volume":"31","author":"Craig","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"2","key":"10.1016\/j.sleep.2025.02.003_bib16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s40120-021-00289-6","article-title":"Current management of residual excessive daytime sleepiness due to obstructive sleep apnea: insights for optimizing patient outcomes","volume":"10","author":"Mehra","year":"2021","journal-title":"Neurol Ther"},{"issue":"5","key":"10.1016\/j.sleep.2025.02.003_bib17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.7326\/M22-3473","article-title":"Comparative efficacy and safety of wakefulness-promoting agents for excessive daytime sleepiness in patients with obstructive sleep apnea","volume":"176","author":"Pitre","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.sleep.2025.02.003_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102843","article-title":"Comparative efficacy, safety and benefit\/risk of alerting agents for excessive daytime sleepiness in patients with obstructive sleep apnoea: a network meta-analysis","volume":"76","author":"P\u00e9pin","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"4","key":"10.1016\/j.sleep.2025.02.003_bib19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1476-5381.2011.01286.x","article-title":"The histamine H3 receptor: from discovery to clinical trials with pitolisant","volume":"163","author":"Schwartz","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.sleep.2025.02.003_bib21","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.chest.2020.09.281","article-title":"Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: a randomized trial","volume":"159","author":"Pepin","year":"2021","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.sleep.2025.02.003_bib22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"issue":"10","key":"10.1016\/j.sleep.2025.02.003_bib23","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.5664\/jcsm.4104","article-title":"The Oxford sleep resistance test (OSLER) and the multiple unprepared reaction time test (MURT) detect vigilance modifications in sleep apnea patients","volume":"10","author":"Alakuijala","year":"2014","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2025.02.003_bib24","series-title":"Cochrane handbook for systematic reviews of interventions version 5.2.0 (updated june 2017)","article-title":"Chapter 8: assessing risk of bias in included studies","year":"2017"},{"issue":"4","key":"10.1016\/j.sleep.2025.02.003_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.sleep.2025.02.003_bib26","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2307\/2531158","article-title":"Procedures for comparing samples with multiple endpoints","volume":"40","author":"O'Brien","year":"1984","journal-title":"Biometrics"},{"key":"10.1016\/j.sleep.2025.02.003_bib27","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.sleep.2025.02.003_bib28","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1016\/j.sleep.2017.11.544","article-title":"Epworth sleepiness scale ESS: determination of a minimum clinically relevant difference","volume":"40","author":"Lehert","year":"2017","journal-title":"Sleep Med"},{"issue":"15","key":"10.1016\/j.sleep.2025.02.003_bib29","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/sim.918","article-title":"Meta-analysis of continuous outcome data from individual patients","volume":"20","author":"Higgins","year":"2001","journal-title":"Stat Med"},{"key":"10.1016\/j.sleep.2025.02.003_bib30","series-title":"Mixed-effects models in S and S-plus, statistics and computing","article-title":"Linear mixed-effects models: basic concepts and examples","author":"Pinheiro","year":"2000"},{"issue":"1","key":"10.1016\/j.sleep.2025.02.003_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Roy Stat Soc B"},{"key":"10.1016\/j.sleep.2025.02.003_bib32","series-title":"Multiple endpoints in clinical trials guidance for industry","year":"2017"},{"issue":"6","key":"10.1016\/j.sleep.2025.02.003_bib33","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1080\/10543406.2013.834911","article-title":"Analysis of longitudinal trials with protocol deviation: a framework for relevant, accessible assumptions, and inference via multiple imputation","volume":"23","author":"Carpenter","year":"2013","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.sleep.2025.02.003_bib34","series-title":"R: a language and environment for statistical computing","year":"2021"},{"issue":"9","key":"10.1016\/j.sleep.2025.02.003_bib35","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1164\/rccm.201907-1284OC","article-title":"Pitolisant for daytime sleepiness in patients with obstructive sleep apnea who refuse continuous positive airway pressure treatment. A randomized trial","volume":"201","author":"Dauvilliers","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.sleep.2025.02.003_bib36","article-title":"Pitolisant 40 mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by CPAP: randomised phase 3 study","author":"Dauvilliers","year":"2024","journal-title":"J Sleep Res"},{"issue":"6","key":"10.1016\/j.sleep.2025.02.003_bib37","first-page":"862","article-title":"[Brief self-evaluation questionnaire for depressive, asthenic and anxious dimensions]","volume":"142","author":"Pichot","year":"1984","journal-title":"Ann Med-Psychol"},{"key":"10.1016\/j.sleep.2025.02.003_bib38","unstructured":"EuroQoL. EQ-5D-5L [May 2024]. Available from: https:\/\/euroqol.org\/information-and-support\/euroqol-instruments\/eq-5d-5l\/."},{"issue":"1","key":"10.1016\/j.sleep.2025.02.003_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40261-021-01104-8","article-title":"Efficacy of pitolisant 20 mg in reducing excessive daytime sleepiness and fatigue in patients with obstructive sleep apnoea syndrome: an individual patient data meta-analysis","volume":"42","author":"Lehert","year":"2022","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.sleep.2025.02.003_bib40","series-title":"Ozawade - European public assessment report","year":"2021"},{"issue":"4","key":"10.1016\/j.sleep.2025.02.003_bib41","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/thoraxjnl-2018-211959","article-title":"Minimum important difference of the Epworth Sleepiness Scale in obstructive sleep apnoea: estimation from three randomised controlled trials","volume":"74","author":"Crook","year":"2019","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.sleep.2025.02.003_bib42","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1164\/rccm.201704-0672LE","article-title":"The Epworth sleepiness scale: minimum clinically important difference in obstructive sleep apnea","volume":"197","author":"Patel","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.sleep.2025.02.003_bib43","article-title":"Continuous positive airway pressure treatment for obstructive sleep apnea, hospitalizations, and related costs in the French National Healthcare Insurance database","volume":"86","author":"Sabil","year":"2024","journal-title":"Respir Med Res"},{"issue":"6","key":"10.1016\/j.sleep.2025.02.003_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.12729","article-title":"Clinical presentation of patients with suspected obstructive sleep apnea and self-reported physician-diagnosed asthma in the ESADA cohort","volume":"27","author":"Bonsignore","year":"2018","journal-title":"J Sleep Res"},{"key":"10.1016\/j.sleep.2025.02.003_bib45","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.sleep.2024.09.039","article-title":"The Swedish sleep apnea registry (SESAR) cohort - \"Real world data\" on a national level","volume":"124","author":"Grote","year":"2024","journal-title":"Sleep Med"},{"issue":"5","key":"10.1016\/j.sleep.2025.02.003_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10050936","article-title":"CPAP therapy termination rates by OSA phenotype: a French nationwide database analysis","volume":"10","author":"P\u00e9pin","year":"2021","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.sleep.2025.02.003_bib47","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.chest.2023.11.017","article-title":"Long-term efficacy and safety of pitolisant for residual sleepiness due to OSA","volume":"165","author":"P\u00e9pin","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.sleep.2025.02.003_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102843","article-title":"Comparative efficacy, safety and benefit\/risk of alerting agents for excessive daytime sleepiness in patients with obstructive sleep apnoea: a network meta-analysis","volume":"76","author":"P\u00e9pin","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.sleep.2025.02.003_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2024.101997","article-title":"Excessive daytime sleepiness in obstructive sleep apnea: indirect treatment comparison of wake-promoting agents in patients adherent\/nonadherent to primary OSA therapy","volume":"78","author":"Wang","year":"2024","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2025.02.003_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2024.101934","article-title":"Evaluating pharmacological treatments for excessive daytime sleepiness in obstructive sleep apnea: a comprehensive network meta-analysis and systematic review","volume":"76","author":"Neshat","year":"2024","journal-title":"Sleep Med Rev"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725000486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725000486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:58:31Z","timestamp":1762545511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945725000486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":49,"alternative-id":["S1389945725000486"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2025.02.003","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of pitolisant in residual excessive daytime sleepiness for patients with obstructive sleep apnea adhering to continuous positive airway pressure therapy in the HAROSA studies: An individual patient meta-analytical approach","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2025.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}